AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Markert, ML Hicks, CB Bartlett, JA Harmon, JL Hale, LP Greenberg, ML Ferrari, G Ottinger, J Boeck, A Kloster, AL McLaughlin, TM Bleich, KB Ungerleider, RM Lyerly, HK Wilkinson, WE Rousseau, FS Heath-Chiozzi, ME Leonard, JM Haase, AT Shaw, GM Bucy, RP Douek, DC Koup, RA Haynes, BF Bolognesi, DP Weinhold, KJ
Citation: Ml. Markert et al., Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection, AIDS RES H, 16(5), 2000, pp. 403-413

Authors: Beyers, JM Leonard, JM Mays, VK Rosen, LA
Citation: Jm. Beyers et al., Gender differences in the perception of courtship abuse, J INTERP V, 15(5), 2000, pp. 451-466

Authors: Purnell, JQ Zambon, A Knopp, RH Pizzuti, DJ Achari, R Leonard, JM Locke, C Brunzell, JD
Citation: Jq. Purnell et al., Effect of ritonavir on lipids and post-heparin lipase activities in normalsubjects, AIDS, 14(1), 2000, pp. 51-57

Authors: Connick, E Lederman, MM Kotzin, BL Spritzler, J Kuritzkes, DR St Clair, M Sevin, AD Fox, L Chiozzi, MH Leonard, JM Rousseau, F Roe, JD Martinez, A Kessler, H Landay, A
Citation: E. Connick et al., Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response, J INFEC DIS, 181(1), 2000, pp. 358-363

Authors: Clark, RD Leonard, JM Strizhev, A
Citation: Rd. Clark et al., Pharmacophore models and Comparative Molecular Field Analysis (CoMFA), IUL BIOTECH, 2, 2000, pp. 151-169

Authors: Cameron, DW Japour, AJ Xu, Y Hsu, A Mellors, J Farthing, C Cohen, C Poretz, D Markowitz, M Follansbee, S Angel, JB McMahon, D Ho, D Devanarayan, V Rode, R Salgo, MP Kempf, DJ Granneman, R Leonard, JM Sun, E
Citation: Dw. Cameron et al., Ritonavir and saquinavir combination therapy for the treatment of HIV infection, AIDS, 13(2), 1999, pp. 213-224

Authors: Arnaout, RA Lloyd, AL O'Brien, TR Goedert, JJ Leonard, JM Nowak, MA
Citation: Ra. Arnaout et al., A simple relationship between viral load and survival time in HIV-1 infection, P NAS US, 96(20), 1999, pp. 11549-11553

Authors: Wu, HL Kuritzkes, DR McClernon, DR Kessler, H Connick, E Landay, A Spear, G Heath-Chiozzi, M Rousseau, F Fox, L Spritzler, J Leonard, JM Lederman, MM
Citation: Hl. Wu et al., Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: Relationships to host factors, cellular restoration, and virologic end points, J INFEC DIS, 179(4), 1999, pp. 799-807

Authors: Markowitz, M Vesanen, M Tenner-Racz, K Cao, YZ Binley, JM Talal, A Hurley, A Ji, X Chaudhry, MR Yaman, M Frankel, S Heath-Chiozzi, M Leonard, JM Moore, JP Racz, P Nixon, DF Ho, DD
Citation: M. Markowitz et al., The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses, J INFEC DIS, 179(3), 1999, pp. 527-537

Authors: Ouellet, D Hsu, A Qian, J Lamm, JE Cavanaugh, JH Leonard, JM Granneman, GR
Citation: D. Ouellet et al., Effect of fluoxetine on pharmacokinetics of ritonavir, ANTIM AG CH, 42(12), 1998, pp. 3107-3112

Authors: Sham, HL Kempf, DJ Molla, A Marsh, KC Kumar, GN Chen, CM Kati, W Stewart, K Lal, R Hsu, A Betebenner, D Korneyeva, M Vasavanonda, S McDonald, E Saldivar, A Wideburg, N Chen, XQ Niu, P Park, C Jayanti, V Grabowski, B Granneman, GR Sun, E Japour, AJ Leonard, JM Plattner, JJ Norbeck, DW
Citation: Hl. Sham et al., ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease, ANTIM AG CH, 42(12), 1998, pp. 3218-3224
Risultati: 1-11 |